MORGAN STANLEY

Position in DNTH — Dianthus Therapeutics, Inc. /DE/

CIK 895421 NEW YORK, NY

Position in DNTH

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$8,178,420

-$1,218,114 QoQ

Shares Held

97,455

-57.3% QoQ

Ownership

0.178%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 70.7208455184444.ToString("F0")% Shared 0.ToString("F0")% None 29.27915448155559.ToString("F0")%

Healthcare · as of Mar 31, 2026

MORGAN STANLEY holds $15,438,935,225 across 518 Biotechnology names. DNTH ranks #153 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	43,571,633	$2,090,131,227
2	ROIV	Roivant Sciences Ltd.	51,828,325	$1,435,644,595
3	VRTX	Vertex Pharmaceuticals Inc / Ma	3,188,881	$1,423,962,911
4	REGN	Regeneron Pharmaceuticals, Inc.	1,319,329	$1,019,366,352
5	TECH	BIO-TECHNE Corp	8,532,873	$445,927,935
6	MRNA	Moderna, Inc.	8,471,263	$430,340,154
7	ARGX	Argenx SE	560,711	$409,459,203
8	APLS	Apellis Pharmaceuticals, Inc.	10,042,399	$404,005,708

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$8,178,420	97,455	-57.3%	Shares	Defined	2026-05-15
2025-12-31	$9,396,534	228,016	+194.1%	Shares	Defined	2026-05-27
2025-09-30	$3,050,408	77,520	-43.8%	Shares	Defined	2026-05-27
2025-06-30	$2,568,124	137,849	+74.1%	Shares	Defined	2025-08-15
2025-03-31	$1,436,104	79,168	-31.8%	Shares	Defined	2025-05-15
2024-12-31	$2,529,865	116,049	+72.5%	Shares	Defined	2025-05-15
2024-09-30	$1,842,260	67,285	+149.6%	Shares	Defined	2025-05-14
2024-06-30	$697,748	26,961	+27.9%	Shares	Defined	2025-05-14
2024-03-31	$632,520	21,084	+38234.5%	Shares	Defined	2024-10-17
2023-12-31	$572	55	-64.5%	Shares	Defined	2024-08-16
2023-09-30	$2,118	155	—	Shares	Defined	2023-11-15
No filing history on record for this holder in this stock.